The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 9,744 | 3,383,290 | SH | SOLE | 3,383,290 | 0 | 0 | ||
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 53,979 | 7,121,283 | SH | SOLE | 7,121,283 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 268 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 34,431 | 5,796,482 | SH | SOLE | 5,796,482 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 47,093 | 3,175,535 | SH | SOLE | 3,175,535 | 0 | 0 | ||
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 100,255 | 6,909,374 | SH | SOLE | 6,909,374 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 37,087 | 3,566,054 | SH | SOLE | 3,566,054 | 0 | 0 | ||
| AXOVANT GENE THERAPIES LTD | COM | G0750W203 | 8,914 | 3,653,303 | SH | SOLE | 3,653,303 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 15,943 | 1,597,503 | SH | SOLE | 1,597,503 | 0 | 0 | ||
| BIOTELEMETRY INC | COM | 090672106 | 1,895 | 49,219 | SH | SOLE | 49,219 | 0 | 0 | ||
| CAREDX INC | COM | 14167L103 | 58,083 | 2,660,716 | SH | SOLE | 2,660,716 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 92,325 | 2,297,779 | SH | SOLE | 2,297,779 | 0 | 0 | ||
| COHERUS BIOSCIENCES INC | COM | 19249H103 | 32,764 | 2,020,002 | SH | SOLE | 2,020,002 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 40,466 | 3,432,232 | SH | SOLE | 3,432,232 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 51,259 | 3,304,918 | SH | SOLE | 3,304,918 | 0 | 0 | ||
| INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 25,431 | 1,654,600 | SH | SOLE | 1,654,600 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 10,838 | 3,150,565 | SH | SOLE | 3,150,565 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 65,401 | 15,608,948 | SH | SOLE | 15,608,948 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 137,941 | 7,180,700 | SH | SOLE | 7,180,700 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 34,687 | 2,240,779 | SH | SOLE | 2,240,779 | 0 | 0 | ||
| KRYSTAL BIOTECH INC | COM | 501147102 | 28,304 | 654,586 | SH | SOLE | 654,586 | 0 | 0 | ||
| LIMINAL BIOSCIENCES INC | COM | 53272L103 | 21,980 | 3,287,311 | SH | SOLE | 3,287,311 | 0 | 0 | ||
| OMEROS CORP | COM | 682143102 | 59,896 | 4,479,872 | SH | SOLE | 4,479,872 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 7,691 | 2,580,878 | SH | SOLE | 2,580,878 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 11,524 | 1,244,460 | SH | SOLE | 1,244,460 | 0 | 0 | ||
| PRINCIPIA BIOPHARMA INC | COM | 74257L108 | 40,955 | 689,718 | SH | SOLE | 689,718 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 33,767 | 2,314,421 | SH | SOLE | 2,314,421 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 80,522 | 823,165 | SH | SOLE | 823,165 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 48,999 | 1,032,636 | SH | SOLE | 1,032,636 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 128,048 | 1,350,360 | SH | SOLE | 1,350,360 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 22,449 | 1,979,669 | SH | SOLE | 1,979,669 | 0 | 0 | ||